ctrl K

Watchlist Price Alert

Ventyx Biosciences Inc. (VTYX)

NASDAQ: VTYX · Real-Time Price · USD

2.21

-0.33 (-12.99%)

At close: Jun 17, 2025, 11:43 AM

Ventyx Biosciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	941K	470K	30K	n/a	n/a
Gross Profit	n/a	-941K	-470K	-30K	n/a	n/a
Operating Income	-148.45M	-207.99M	-113.14M	-67.15M	-7.05M	-4.18M
Interest Income	n/a	15.07M	4.67M	78K	358.00	146.00
Pretax Income	-135.12M	-192.96M	-108.43M	-83.75M	-28.17M	-4.33M
Net Income	-135.12M	-192.96M	-107.96M	-78.37M	-28.53M	-4.47M
Selling & General & Admin	31.45M	32.23M	25.4M	8.67M	684K	628K
Research & Development	117M	175.77M	87.74M	58.48M	6.37M	3.55M
Other Expenses	n/a	0.00	41K	-5.45M	-1K	-1K
Operating Expenses	148.45M	207.99M	113.14M	67.15M	7.05M	4.18M
Interest Expense	n/a	n/a	n/a	99K	358K	146K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	207.99M	113.14M	67.15M	7.05M	4.18M
Income Tax Expense	n/a	n/a	-470K	-5.38M	358K	146K
Shares Outstanding (Basic)	68.48M	58.54M	52.47M	50.41M	50.3M	50.3M
Shares Outstanding (Diluted)	68.48M	58.54M	52.47M	50.41M	50.3M	50.3M
EPS (Basic)	-1.97	-3.3	-2.06	-1.55	-0.57	-0.09
EPS (Diluted)	-1.97	-3.3	-2.06	-1.55	-0.57	-0.09
EBITDA	-133.77M	-207.84M	-107.96M	-67.12M	n/a	-1K
EBIT	-135.12M	-207.99M	-108.43M	-67.15M	-7.05M	-4.18M
Depreciation & Amortization	1.35M	158K	470K	30K	7.05M	4.18M